1. PURPOSE

LIDOCAINE

To authorize CCP’s to monitor and adjust existing intravenous Lidocaine infusions during transport

2. POLICY

2.1. CCP’s are permitted to monitor and adjust Lidocaine infusions during transport and care.
2.2. CCP’s may not initiate Lidocaine infusions.

3. PROCEDURE

3.1. Lidocaine Infusion Parameters

3.1.1.  Infuse fluid will be either NS or D5W.
3.1.2.  Typical concentrations are 1 gm/250 ml or 2 gm/500 ml.
3.1.3.  Regulation of the infusion rate will occur within the parameters as defined by the
transferring physician but no greater than 1 mg/min increments q 3-5 mins.

3.1.4.  CCP’s may institute two (2) infusion rate changes prior to consulting with the

transferring physician or base hospital.

3.1.5.  Any additional changes MUST be made only after contact with the transferring

physician or base hospital.

Standard Strength

1 Gram/250 cc D5W or NS or 2 Gm/500 cc

cc/hr
15
30
45
60

mg/min
1
2
3
4

18

